Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) ...

The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...

There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...

Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their perceptions about the causes of obesity and treatment goals.

Viking Therapeutics became famous in the biotech world last year after announcing positive phase 2 results for VK2735, an ...

The best metric is not weight, but a particularly toxic kind of fat.

In the first direct comparison study involving individuals with obesity, tirzepatide demonstrated approximately 50% greater ...

A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their perceptions about the ...

Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...